About Elder Pharmaceuticals Limited
Data last updated:
Elder Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 1983.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24239MH1983PLC029714. The company has 24 GST registrations on record, none of which is active. It is recorded as listed by MCA, but its shares were delisted from NSE on 30 May 2018 · winding up and from BSE on 11 May 2018 · compulsory delisting, and no longer trade on a stock exchange.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹20.54 Cr. It is led by directors including Alok Jagdish Saxena (Managing Director) and Abdul Khader Mohammed Ravani.
Its last annual general meeting (AGM) was held on 30 December 2013, and its latest financial statements are for the year ended 30 June 2013. The registered office is at Elder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, India – 400058.
As per the financials filed for FY 2013, the company reported a revenue of ₹1,259.31 Cr, a growth of 25% compared to the previous year.
As per MCA filings, the company has open charges of ₹338.1 Cr and satisfied charges of ₹3,335.92 Cr on record. Court records list 1,017 cases involving the company, including 283 filed by the company and 734 filed against it; 127 cases are pending. The company has 36 deals on record (32 market trades, 2 acquisitions, 1 qip), with disclosed funding of ₹38.66 Cr; the latest was in January 2015. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Onesource Specialty Pharma Limited with revenue of ₹1,462.33 Cr.
The last known website on record is elderindia.com.
Company details
CIN history
Elder Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1983PLC029714. The current CIN is L24239MH1983PLC029714, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24239MH1983PLC029714 | Current |
| U24239MH1983PLC029714 | Previous |
Contact details
Elder Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressElder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, India – 400058
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Elder Pharmaceuticals Limited
FY 2013 filings availableElder Pharmaceuticals Limited reported revenue of ₹1,259.31 Cr (up 25% YoY) for FY 2013.
Compounded Annual Growth Rate (CAGR)
Revenue rose 25% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2012-13 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2012-13 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Elder Pharmaceuticals Limited, buy the company report.
Board of directors of Elder Pharmaceuticals Limited
Elder Pharmaceuticals has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alok Jagdish Saxena | Managing Director | 29 Aug 2002 | 24 Years 1 Months | As last reported |
| Abdul Khader Mohammed Ravani | Additional Director | 25 Jan 2016 | 10 Years 8 Months | As last reported |
| Kader Mohamed Davawala | Additional Director | 25 Jan 2016 | 10 Years 8 Months | As last reported |
Peer comparison
Elder Pharmaceuticals Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Onesource Specialty Pharma Limited | ₹1,462.33 Cr (FY 2025) | 730.0% | Thane, Maharashtra, India | |||
| Par Formulations Private Limited | ₹1,462.09 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Encube Ethicals Private Limited | ₹1,369 Cr (FY 2025) | 25.0% | Mumbai, Maharashtra, India | |||
| Shasun Pharmaceuticals Limited | ₹1,328.86 Cr (FY 2015) | 8.0% | Chennai, Tamil Nadu, India | |||
| Sentiss Pharma Private Limited | ₹1,262.74 Cr (FY 2025) | 43.0% | New Delhi, Delhi, India | |||
| Elder Pharmaceuticals Limitedthis company | ₹1,259.31 Cr (FY 2013) | 25.0% | Mumbai, Maharashtra, India | |||
| Innova Captab Limited | ₹1,255.72 Cr (FY 2025) | 15.0% | Thane, Maharashtra, India | |||
| Mylan Pharmaceuticals Private Limited | ₹1,253.34 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Cipla Health Limited | ₹1,228.87 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Neon Laboratories Limited | ₹1,222.81 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Corona Remedies Limited | ₹1,202.35 Cr (FY 2025) | 18.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Elder Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Oct 2014 | 10531139 | Dcb Bank Limited | ₹16 Cr | Open | |
| 30 Jul 2014 | 10514198 | Bank of India | ₹35 Cr | Open | |
| 19 Nov 2012 | 10388957 | Axis Trustee Services Limited | ₹70 Cr | Open | |
| 28 Jun 2011 | 10298055 | Axis Trustee Services Limited | ₹73 Cr | Open | |
| 21 Mar 2011 | 10279504 | Axis Trustee Services Limited | ₹118.8 Cr | Open |
To see the full charge records of Elder Pharmaceuticals Limited, buy the company report.
Total charge records: 176 View all charges
Deals & funding
Elder Pharmaceuticals Limited has 36 deals on record (32 market trades, 2 acquisitions, 1 qip), with disclosed funding of ₹38.66 Cr; the latest was in January 2015.
Deals on record (5 of 36)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2015 | Market trade | ₹3.2 Cr | Buyer: Millennium Stock Broking Private Limited Seller: Millennium Stock Broking Private Limited |
| Mar 2014 | Market trade | ₹2.39 Cr | Buyer: Monet Securities Pvt. Ltd. Seller: Supreme Wood Products Pvt Ltd |
| Jan 2014 | Market trade | ₹2.74 Cr | Buyer: Crosseas Capital Markets Private Limited Seller: Crosseas Capital Markets Private Limited |
| Dec 2013 | Acquisition | ₹2,004 Cr | Buyer: Torrent Pharmaceuticals Ltd Seller: Elder Pharmaceuticals Limited |
| Dec 2013 | Market trade | ₹6.61 Cr | Buyer: Crosseas Capital Markets Private Limited Seller: Crosseas Capital Markets Private Limited |
To see the full deal history of Elder Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Elder Pharmaceuticals Limited has 1,017 court cases on record: 283 filed by Elder Pharmaceuticals, 734 filed against it. 127 cases are pending and 890 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 600 | 401 | 26 |
| District courts | 414 | 331 | 100 |
| Supreme Court | 2 | 1 | 0 |
| NCLT | 1 | 1 | 1 |
Cases on record (5 of 1,017)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Court case ((T)OP(TM)) | Filed by the company against M/S.Uniorange Life Care Pvt. Ltd., and 1 other | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Blessings Trades Pvt Ltd | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Torrent Pharmaceuticals Limited | Disposed |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Dayco Commodity Brokers LLP | Disposed |
| High Court | Interim or miscellaneous application | Filed against the company by Jay Kumar Garg Director of Elder Pharmacia LLP Mulani and Co | Disposed |
To see the full case history of Elder Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elder Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elder Pharmaceuticals has 24 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Elder Pharmaceuticals Limited, buy the company report.
Recent activity
Elder Pharmaceuticals Limited has 37 board changes on record since 1983: 20 appointments and 17 cessations. The latest: Abdul Khader Mohammed Ravani was appointed as Additional Director on 25 Jan 2016.
431 earlier events are in the company report.
Frequently asked questions
Elder Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Elder Pharmaceuticals is a company under liquidation, formerly operating as a public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 1983 and is registered under CIN L24239MH1983PLC029714. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Elder Pharmaceuticals has 3 current directors:
- Alok Jagdish Saxena - Managing Director
- Abdul Khader Mohammed Ravani - Additional Director
- Kader Mohamed Davawala - Additional Director
The latest financial statements of Elder Pharmaceuticals on record with the MCA are for the year ended 30 June 2013. Its last annual general meeting was held on 30 December 2013. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Elder Pharmaceuticals is L24239MH1983PLC029714. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elder Pharmaceuticals is recorded as a listed company by MCA, but its shares were delisted from NSE on 30 May 2018 · winding up and from BSE on 11 May 2018 · compulsory delisting, and no longer trade on a stock exchange.
Elder Pharmaceuticals has open charges of ₹338.1 Cr and satisfied charges of ₹3,335.92 Cr as per latest MCA filings.
Elder Pharmaceuticals has 1,017 court cases on record: 283 filed by the company and 734 filed against it. 127 are pending. Most are in the high courts.
Elder Pharmaceuticals was incorporated on 02 April 1983. It is registered with the Registrar of Companies, Mumbai.
Elder Pharmaceuticals has 36 deals on record (32 market trades, 2 acquisitions, 1 qip), with disclosed funding of ₹38.66 Cr; the latest was in January 2015.
The peers of Elder Pharmaceuticals by revenue are Onesource Specialty Pharma Limited, Par Formulations Private Limited, Encube Ethicals Private Limited, Shasun Pharmaceuticals Limited, Sentiss Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).